| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| D Attar-Lévy, J L Martinot, J Blin, M H Dao-Castellana, C Crouzel, B Mazoyer, M F Poirier, M C Bourdel, N Aymard, A Syrota, A Félin. The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine. Biological psychiatry. vol 45. issue 2. 1999-05-24. PMID:9951565. |
changes in serotonin (5-ht)2 receptor densities were reported in depression by postmortem studies and following treatment with tricyclic antidepressants in animal studies. |
1999-05-24 |
2023-08-12 |
Not clear |
| J S Arche. NAMS/Solvay Resident Essay Award. Relationship between estrogen, serotonin, and depression. Menopause (New York, N.Y.). vol 6. issue 1. 1999-05-20. PMID:10100184. |
relationship between estrogen, serotonin, and depression. |
1999-05-20 |
2023-08-12 |
Not clear |
| A Ro. Suicidal behavior in depression: relationship to platelet serotonin transporter. Neuropsychobiology. vol 39. issue 2. 1999-05-19. PMID:10072662. |
suicidal behavior in depression: relationship to platelet serotonin transporter. |
1999-05-19 |
2023-08-12 |
Not clear |
| A Ro. Suicidal behavior in depression: relationship to platelet serotonin transporter. Neuropsychobiology. vol 39. issue 2. 1999-05-19. PMID:10072662. |
thus, platelet serotonin uptake in relation to suicidal behavior in depression was examined. |
1999-05-19 |
2023-08-12 |
Not clear |
| W Poewe, E Luginge. Depression in Parkinson's disease: impediments to recognition and treatment options. Neurology. vol 52. issue 7 Suppl 3. 1999-05-10. PMID:10227602. |
therapeutic mainstays for parkinsonian depression include psychosocial counseling at the time of pd diagnosis (and during advanced stages of pd) as well as appropriate medication regimens, the relative clinical efficacy of which remain a matter of ongoing clinical inquiry: levodopa, dopamine agonists, selegilene, tricyclic antidepressants, and selective serotonin reuptake inhibitors). |
1999-05-10 |
2023-08-12 |
Not clear |
| L Cot. Depression: impact and management by the patient and family. Neurology. vol 52. issue 7 Suppl 3. 1999-05-10. PMID:10227603. |
serotonin depletion probably underlies the pathophysiology of this condition, in that cerebrospinal-fluid levels of serotonin's terminal metabolite decline to a greater extent in parkinsonian depression than in uncomplicated pd. |
1999-05-10 |
2023-08-12 |
Not clear |
| J Levine, A Mishori, M Susnosky, M Martin, R H Belmake. Combination of inositol and serotonin reuptake inhibitors in the treatment of depression. Biological psychiatry. vol 45. issue 3. 1999-05-07. PMID:10023500. |
combination of inositol and serotonin reuptake inhibitors in the treatment of depression. |
1999-05-07 |
2023-08-12 |
Not clear |
| R J Kavoussi, R L Hauger, E F Coccar. Prolactin response to d-fenfluramine in major depression before and after treatment with serotonin reuptake inhibitors. Biological psychiatry. vol 45. issue 3. 1999-05-07. PMID:10023505. |
prolactin response to d-fenfluramine in major depression before and after treatment with serotonin reuptake inhibitors. |
1999-05-07 |
2023-08-12 |
Not clear |
| R J Kavoussi, R L Hauger, E F Coccar. Prolactin response to d-fenfluramine in major depression before and after treatment with serotonin reuptake inhibitors. Biological psychiatry. vol 45. issue 3. 1999-05-07. PMID:10023505. |
central serotonin dysfunction is thought to be involved in the etiology of major depression. |
1999-05-07 |
2023-08-12 |
Not clear |
| A J Elliott, J Russo, K Bergam, K Claypoole, K K Uldall, P P Roy-Byrn. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone. The Journal of clinical psychiatry. vol 60. issue 4. 1999-05-06. PMID:10221282. |
treatment studies of major depression in patients who are seropositive for the human immunodeficiency virus (hiv) have shown comparable efficacy for both tricyclic antidepressants (tcas) and selective serotonin reuptake inhibitors (ssris). |
1999-05-06 |
2023-08-12 |
human |
| R B Ostroff, J C Nelso. Risperidone augmentation of selective serotonin reuptake inhibitors in major depression. The Journal of clinical psychiatry. vol 60. issue 4. 1999-05-06. PMID:10221288. |
risperidone augmentation of selective serotonin reuptake inhibitors in major depression. |
1999-05-06 |
2023-08-12 |
Not clear |
| D R Rubinow, P J Schmidt, C A Roc. Estrogen-serotonin interactions: implications for affective regulation. Biological psychiatry. vol 44. issue 9. 1999-05-04. PMID:9807639. |
finally, we summarize the putative roles of estrogen and serotonin in two reproductive-endocrine-related mood disorders: premenstrual syndrome and perimenopausal depression. |
1999-05-04 |
2023-08-12 |
Not clear |
| E Frank, M E Thas. Natural history and preventative treatment of recurrent mood disorders. Annual review of medicine. vol 50. 1999-04-30. PMID:10073289. |
current issues in the pharmacotherapy of mood disorders are discussed, including the relative efficacy of the older antidepressants versus the newer selective serotonin reuptake inhibitors (ssris) and the treatment of various subtypes of mood disorders, including dysthymia, chronic depression, and atypical depression. |
1999-04-30 |
2023-08-12 |
Not clear |
| D Parker, S Grillne. Activity-dependent metaplasticity of inhibitory and excitatory synaptic transmission in the lamprey spinal cord locomotor network. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 19. issue 5. 1999-04-20. PMID:10024351. |
substance p induced significant activity-dependent depression of inhibitory but potentiation of excitatory interneuron inputs, whereas 5-ht induced significant activity-dependent potentiation of both inhibitory and excitatory interneuron inputs. |
1999-04-20 |
2023-08-12 |
Not clear |
| F Mentré, J L Golmard, J M Launay, V Aubin-Brunet, M Bouhassira, R Jouven. Relationships between low red blood cell count and clinical response to fluoxetine in depressed elderly patients. Psychiatry research. vol 81. issue 3. 1999-04-19. PMID:9925192. |
biological variables specifically linked with serotonin deficiency were assessed in geriatric depression. |
1999-04-19 |
2023-08-12 |
Not clear |
| W Rutz, J Wålinder, Z Rhimer, P Pestalit. [Male depression--stress reaction combined with serotonin deficiency?]. Lakartidningen. vol 96. issue 10. 1999-04-15. PMID:10193121. |
[male depression--stress reaction combined with serotonin deficiency?]. |
1999-04-15 |
2023-08-12 |
Not clear |
| A Erfurth, B Amann, H Grunz. Female genital disorder as adverse symptom of lamotrigine treatment. A serotoninergic effect? Neuropsychobiology. vol 38. issue 3. 1999-04-02. PMID:9778610. |
its efficacy in bipolar depression might be linked to its inhibition of serotonin uptake. |
1999-04-02 |
2023-08-12 |
Not clear |
| J J Strik, A Honig, R Lousberg, E C Cheriex, H M Van Praa. Cardiac side-effects of two selective serotonin reuptake inhibitors in middle-aged and elderly depressed patients. International clinical psychopharmacology. vol 13. issue 6. 1999-03-29. PMID:9861576. |
selective serotonin reuptake inhibitors (ssris) are the 'new' drugs of first choice for the treatment of depression in the older patient. |
1999-03-29 |
2023-08-12 |
Not clear |
| A F Schatzber. Antidepressant effectiveness in severe depression and melancholia. The Journal of clinical psychiatry. vol 60 Suppl 4. 1999-03-25. PMID:10086479. |
while outcome has improved in patients with depressive disorders since the introduction of the newer antidepressants, some physicians still treat severely depressed patients with the older tricyclic antidepressants because of conflicting reports about the efficacy of the newer agents, particularly the selective serotonin reuptake inhibitors, in severe depression. |
1999-03-25 |
2023-08-12 |
Not clear |
| A Harkin, J P Kelly, M McNamara, T J Connor, K Dredge, A Redmond, B E Leonar. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. European journal of pharmacology. vol 364. issue 2-3. 1999-03-24. PMID:9932714. |
the present study investigated the effects of reboxetine, a new antidepressant that selectively inhibits noradrenaline reuptake, sertraline, a selective serotonin reuptake inhibitor and a combination treatment composed of the two drugs in the olfactory bulbectomized (ob) rat model of depression. |
1999-03-24 |
2023-08-12 |
rat |